The novel approach of this peptide represents a exciting development in the handling of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – GLP-1 and GIP – resulting in https://tirzepatide-peptide948461.p2blogs.com/40342327/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment